You are about to leave the Clinical Value website now.


Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update

Quick Summary

The fourth version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence-based medicine and partly to the Grading of Recommendations Assessment, Development, and Evaluation system, which was published in October 2017 in Japanese. New or revised recommendations were described, herein, with a special reference to the surveillance, diagnostic, and treatment algorithms.

Authors: Norihiro KokudoNobuyuki TakemuraKiyoshi HasegawaTadatoshi TakayamaShoji KuboMitsuo ShimadaHiroaki NaganoEtsuro HatanoNamiki IzumiShuichi KanekoMasatoshi KudoHiroko IijimaTakuya GendaRyosuke TateishiTakuji TorimuraHiroshi IgakiSatoshi KobayashiHideyuki SakuraiTakamichi MurakamiTakeyuki WatadaniYutaka Matsuyama

You May Also Like

The Practice in Japan: Insights into gold standard HCC surveillance and management

Read More
9 December 2022

Liver Cancer in Japan: Dr Shun Kaneko on HCC Screening and Surveillance

Japan is a global leader in hepatocellular carcinoma (HCC) surveillance, with an effective programme that enables early-stage carcinomas detection. Yet unmet needs continue to affect the management of HCC. Learn…

Read More
17 March 2023

Utility of Combining PIVKA-II and AFP in the Surveillance and Monitoring of Hepatocellular Carcinoma in the Asia-Pacific Region

A panel of 17 experts from Asia-Pacific, gathered to discuss and reach a consensus on the clinical usefulness and value of PIVKA-II for the surveillance and treatment monitoring of HCC,…

Read More


Be the first to receive updates, event opportunities, and thought leadership insights.